Particle.news
Download on the App Store

Childhood Cancer Survivor Shares Stage 4 ERMS Journey to Shape Research Priorities

She speaks in a Cancer Research UK Instagram Q&A as a member of its Children and Young People Insights Panel.

Overview

  • She was diagnosed at 14 with embryonal rhabdomyosarcoma that began in her face and later progressed to stage 4 in her lungs.
  • She described intensive treatment consisting of about a year of chemotherapy followed by radiotherapy to her face and chest.
  • She now contributes to Cancer Research UK's Children and Young People Insights Panel to elevate quality-of-life and survivorship needs.
  • She reported receiving a breast cancer diagnosis at age 32 after noticing concerning symptoms.
  • Cancer Research UK outlines ERMS as a pediatric soft-tissue sarcoma that can respond well to combined treatments and urges anyone with worrying signs to see a GP for specialist referral.